Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Pharmaceutical Statistics
|
September 1, 2018
Bayesian detection of potential risk using inference on blinded safety data
Saurabh Mukhopadhyay, Brian Waterhouse, Alan Hartford
Plos One
|
March 21, 2015
Quality of life, safety and efficacy profile of thermostable flolan in pulmonary arterial hypertension
Steeve Provencher, Patrap Paruchuru, Andrea Spezzi, et al.
Pharmaceutical Statistics
|
November 2, 2021
Using the Bayesian detection of potential risk using inference on blinded safety data (BDRIBS) method to support the decision to refer an event for unblinded evaluation
Brian Waterhouse, Alan Hartford, Saurabh Mukhopadhyay, et al.
The American Journal of Cardiology
|
October 7, 2006
Cardiovascular risk factors in hypertension: rationale and design of studies to investigate the effects of controlled-release carvedilol on regression of left ventricular hypertrophy and lipid profile
George L Bakris, Elizabeth A Tarka, Brian Waterhouse, et al.
Open Heart
|
September 16, 2017
Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitus
Radzi M Noh, Sowmya Venkatasubramanian, Shruti Daga, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 11, 2016
Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study
Jean-Luc Vachiéry, Marius M Hoeper, Andrew J Peacock, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 16, 2005
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes
George L Bakris, Vivian Fonseca, Richard E Katholi, et al.
Yonsei Medical Journal
|
May 19, 2016
Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension
Jung Min Koh, Dong Jin Chung, Yoon Sok Chung, et al.
Yonsei Medical Journal
|
May 19, 2016
Vitamin D Repletion in Korean Postmenopausal Women with Osteoporosis
Yoon Sok Chung, Dong Jin Chung, Moo Il Kang, et al.
Indian Journal of Endocrinology and Metabolism
|
January 17, 2015
A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis
Shailesh Pitale, Mathew Thomas, Gaurav Rathi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Pharmaceutical Statistics
|
September 1, 2018
Bayesian detection of potential risk using inference on blinded safety data
Saurabh Mukhopadhyay, Brian Waterhouse, Alan Hartford
Plos One
|
March 21, 2015
Quality of life, safety and efficacy profile of thermostable flolan in pulmonary arterial hypertension
Steeve Provencher, Patrap Paruchuru, Andrea Spezzi, et al.
Pharmaceutical Statistics
|
November 2, 2021
Using the Bayesian detection of potential risk using inference on blinded safety data (BDRIBS) method to support the decision to refer an event for unblinded evaluation
Brian Waterhouse, Alan Hartford, Saurabh Mukhopadhyay, et al.
The American Journal of Cardiology
|
October 7, 2006
Cardiovascular risk factors in hypertension: rationale and design of studies to investigate the effects of controlled-release carvedilol on regression of left ventricular hypertrophy and lipid profile
George L Bakris, Elizabeth A Tarka, Brian Waterhouse, et al.
Open Heart
|
September 16, 2017
Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitus
Radzi M Noh, Sowmya Venkatasubramanian, Shruti Daga, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 11, 2016
Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study
Jean-Luc Vachiéry, Marius M Hoeper, Andrew J Peacock, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 16, 2005
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes
George L Bakris, Vivian Fonseca, Richard E Katholi, et al.
Yonsei Medical Journal
|
May 19, 2016
Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension
Jung Min Koh, Dong Jin Chung, Yoon Sok Chung, et al.
Yonsei Medical Journal
|
May 19, 2016
Vitamin D Repletion in Korean Postmenopausal Women with Osteoporosis
Yoon Sok Chung, Dong Jin Chung, Moo Il Kang, et al.
Indian Journal of Endocrinology and Metabolism
|
January 17, 2015
A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis
Shailesh Pitale, Mathew Thomas, Gaurav Rathi, et al.
Page
of 1